"10.1371_journal.pone.0101301","plos one","2014-07-02T00:00:00Z","Ted Wun; Lori Styles; Laura DeCastro; Marilyn J Telen; Frans Kuypers; Anthony Cheung; William Kramer; Henry Flanner; Seungshin Rhee; John L Magnani; Helen Thackray","Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, California, United States of America; Clinical and Translational Sciences Center, UC Davis School of Medicine, Sacramento, California, United States of America; Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Sacramento, California, United States of America; VA Northern California Health Care System, Sacramento, California, United States of America; Childrens Hospital and Research Institute Oakland, Oakland, California, United States of America; Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Kramer Consulting LLC, North Potomac, Maryland, United States of America; GlycoMimetics, Inc, Gaithersburg, Maryland, United States of America; Rho, Inc., Chapel Hill, North Carolina, United States of America","Conceived and designed the experiments: TW MT AC FK HF JM HT. Performed the experiments: TW LS LD MT AC HF FK. Analyzed the data: TW AC WK FK SR HT. Contributed reagents/materials/analysis tools: AC HF FK. Wrote the paper: TW FK JM HT.","H.F., J.M., and H.T. are employees and have equity interest in Glycomimetics, Inc., which owns the patents to GMI 1070. W.K. has equity interest in Kramer Consulting, LLC, but has no commercial interest in GMI 1070. S.R. is an employee of Rho, Inc., but has no commercial interest in GMI 1070. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","07","Ted Wun","TW",11,TRUE,7,7,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
